Marcolina ST. Wild chamomile mouth rinse and oral glutamine suspension for chemotherapy-induced mocositis. Altern Med Alert 2006;9(1):4-9.
Greenfield RH. Something's fishy--a supplement for UC? Altern Med Alert 2006;9(1):10-11.
Greenfield RH. Green without a sheen? Organics and children. Altern Med Alert 2006;9(1):11-12.
Greenfield RH. Placebo effect: The brain and pain. Altern Med Alert 2006;9(1):12.
Authors: William J. Kennedy, DO, Fellow, Palliative Care Services, Mount Carmel Health, Columbus, OH; Philip H. Santa-Emma, MD, Medical Director, Palliative Care Services, Mount Carmel Health, Columbus, OH; and Robert M. Taylor, MD, Medical Director, Palliative Care Services, Mount Carmel Health, Columbus, OH. Peer Reviewer: Lynn McDonald, MD, Medical Director, Hospice of Kankakee Valley, Bourbonnais, IL.
Beta-Blockers Therapy for the Treatment of Hypertension; Treatments for Acute Migraine; Statin Therapy for ACS Patients; The Correct Dosing for Onychomycosis; FDA Actions
Patients who receive extended anticoagulation are protected from recurrent VTE while receiving long-term therapy. The clinical benefit is maintained after anticoagulation is discontinued, but the magnitude of the benefit is less pronounced.
Following a priority review, the FDA has approved deferasirox, the first oral iron chelator for the treatment of chronic iron overload due to transfusions. It will be marketed by Novartis Pharmaceuticals as Exjade®.
